Free Email Consultation
Planning your first study in UK but do not know where to start? We are here to help you. Contact us for free consultation and advice.
Supporting our clients` success
Your project is important for us!
Could response-based dose be the future of patient care?
FDA report showed that most drugs are effective in only 25-62% of the patients. That probably make you wonder why they are approved and prescribed to patients? The answer to this question is not simple. Many approved drugs have a range of therapeutic dose which could...
Adopting orphan drugs in different therapeutic areas
What happens if a newly developed drug fails in the tested indication? Very often such drugs are abandoned if the developers think they will not be able to be used for different indications or therapeutic areas. In such cases these drugs are classified as ‘orphaned...
Benefits and Challenges of Developing Companion Diagnostics
Personalised medicine is a very popular topic in healthcare as a path towards better and cost-effective treatment of patients. However, we are not there yet due to various reasons. One of the major reasons is lack of diagnostic tests that will equip clinicians with...
Can we predict adverse reactions?
One of the big challenges in drug development is our limited ability to identify potential adverse reactions associated with new therapeutics. Pharmacogenomics provides a great opportunity in understanding the mechanisms of action of drugs and predict not just their...
Can AL help speed up drug development?
Artificial intelligence and machine-learning are novel exciting tools which we hope will help drug development. AI is analysis of very large data sets with statistical machine-learning methods. The simple way of explaining the role of AI is that it could be used in...
3D printing and its potential application in drug development
Three-dimensional printing (3D printing) is gaining popularity in different areas from manufacturing to medicine. It is believed to be considered the beginning of the new industrial revolution. Not surprising 3D printing is also gaining popularity in drug development...
Why new drugs fail?
According to current data average time and cost of a new drug to reach the market is 12 years and costs £1.15 billion but what is not included in this statistics is the fact that many new potential drugs never make it to the market due to various reasons. European...
Practical Clinical Trials, Issue 4 2017
We are happy to release out annual edition of Practical Clinical Trials magazine for 2017. It features materials which were published on our web site in 2017. It includes some very exciting reviews on latest trends in oncology therapy and diagnostics and lots of...
Practical Clinical Trials Magazine, issue 3 2016
This is the third edition of our free magazine Practical Clinical Trials, which represents articles published in 2016. You can download the magazine here: DOWNLOAD Please follow and like...
White paper: Clinical trials – Recruitment strategies
This white paper is dedicated to one of the clinical research communities’ hot topics – recruitment. We will discuss different recruitment strategies and their advantages and disadvantages from practical point of view and also we hope to give some new ideas for...
Free magazine: Practical Clinical Trials, issue 2 2015
We are happy to present the second edition of our free annual magazine “Practical Clinical Trials”, which contains reviews and analysis on clinical trials set up, SAE reporting, regulatory requirements, etc. Download here Please follow and like...